Target Validation – In the Era of Genomics, Big Data, and AI

Target Validation – In the Era of Genomics, Big Data, and AI is organized by Wellcome Connecting Science Courses and Conferences and will be held from Sep 21 - 23, 2026 at Wellcome Genome Campus, Hinxton, England, United Kingdom.

Description:
Advances in genomics, big data, and artificial intelligence (AI) are transforming biomedical research, enabling the identification and validation of therapeutic targets with precision at unprecedented scale.

This conference will bring together leading researchers and thought experts from academia, biotech, and pharma. The meeting will focus on the critical elements that power therapeutic hypothesis building, including large-scale genomics data generation and target selection strategies across modalities and therapeutic areas—with AI and emerging technologies taking centre stage.  The meeting will explore how these innovations are reshaping the path from discovery to the clinic in both common and rare diseases.

The meeting will feature inspiring talks from leading experts, dynamic poster sessions with pitch talks, and exceptional opportunities to connect and collaborate across the research and industry community.